All treatments
Treatment
Placebo tiragolumab clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide with or Without Tiragolumab (Anti-Tigit Antibody) in Patients with Untreated Extensive-Stage Small Cell Lung Cancer
This study is looking into new ways to treat a serious type of lung cancer called small cell lung cancer. It combines standard chemotherapy with a new drug, tiragolumab, and an existing cancer drug, Tecentriq, to see if this mix works better than current treatments.
For: Small cell lung cancer (SCLC)Greece · Italy · Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of Tiragolumab, an Anti-Tigit Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
This study is for people with a certain type of advanced lung cancer that hasn't been treated before. It tests a new drug, tiragolumab, combined with an existing drug, atezolizumab, to see if this combination works better than atezolizumab alone. The aim is to find ways to help people live longer and with better quality of life.
For: Non-small cell lung cancer (NSCLC)Germany · Hungary · Italy